Probiotic Lactobacillus gasseri SBT2055 improves insulin secretion in a diabetic rat model

M. Niibo, B. Shirouchi, M. Umegatani, Y. Morita, A. Ogawa, F. Sakai, Y. Kadooka, M. Sato

研究成果: ジャーナルへの寄稿学術誌査読

55 被引用数 (Scopus)


The probiotic Lactobacillus gasseri SBT2055 (LG2055) has a protective effect against metabolic syndrome in rats and humans. Metabolic syndrome increases the risk of type 2 diabetes mellitus. In this study, Goto-Kakizaki rats were used as a diabetic model and fed diets containing LG2055-fermented or nonfermented skim milk for 4 wk. Indices of diabetes such as blood glucose levels, serum glucagon levels, plasma levels of insulin, C-peptide, and glucagon-like peptide-1, tissue glycogen contents, and pancreatic mRNA levels were measured. The plasma C-peptide levels and pancreatic mRNA levels of insulin genes (Ins1 and Ins2) and Pdx1 (a transcriptional factor of insulin genes) were increased in LG2055 diet-fed rats. The increase in insulin secretion corresponded to an improvement in serum and pancreatic inflammatory status, associated with decreases in serum levels of serum amyloid P and pancreatic levels of granulocyte colony-stimulating factor. Insulin resistance in Goto-Kakizaki rats was ameliorated by increased glycogen storage in the liver and quadriceps femoris muscles and decreased serum free fatty acid levels. This improvement may be related to the increased cecal production of short-chain fatty acids. In conclusion, dietary LG2055 improved insulin secretion in diabetic rats by improving the inflammatory status in the pancreas and serum.

ジャーナルJournal of Dairy Science
出版ステータス出版済み - 2月 2019

!!!All Science Journal Classification (ASJC) codes

  • 食品科学
  • 動物科学および動物学
  • 遺伝学


「Probiotic Lactobacillus gasseri SBT2055 improves insulin secretion in a diabetic rat model」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。